Ligand Pharmaceuticals Inc. Contingent Value Right (LGNDZ)
Market Closed
20 Jul, 20:00
OTC PINK OTC PINK Primary $
0. 00
+0
+46.1538%
$
38.08K Market Cap
- P/E Ratio
- Div Yield
2 Volume
0 Eps
$ 0
Previous Close Want to track LGNDZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.84 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LGNDZ Earnings Reports FAQ
What is the earnings per share (EPS) for LGNDZ?
The current EPS is 0.
What is the company's earnings growth rate?
Ligand Pharmaceuticals Inc. Contingent Value Right has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Ligand Pharmaceuticals Inc. Contingent Value Right has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ligand Pharmaceuticals Inc. Contingent Value Right are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LGNDZ at this time, as Ligand Pharmaceuticals Inc. Contingent Value Right has no recent EPS data to calculate it.
